Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 6,275 NBIX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 6,275 | n/a |
| Sep 11, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 3,194 | $138.1K |
| May 13, 2026 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Feb 17, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,005 | n/a |
| Feb 3, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,294 | n/a |
| Dec 2, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 5,970 | $214.9K |
| May 2, 2025 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Feb 14, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,083 | n/a |
| Feb 12, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,860 | n/a |
| Feb 4, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,294 | n/a |